Diabetes mellitus: what the neurologists need to know

被引：2

作者：

Stephens, Jeffrey Wayne ^{[1
]}

Williams, David M. ^{[2
]}

Chudleigh, Richard ^{[3
]}

机构：

[1] Swansea Univ Med Sch, Diabetes Res Grp, Swansea, W Glam, Wales

[2] Morriston Hosp, Diabetes Ctr, Swansea, W Glam, Wales

[3] Singleton Hosp, Diabetes Ctr, Swansea, W Glam, Wales

来源：

PRACTICAL NEUROLOGY | 2022年 / 22卷 / 06期

关键词：

diabetes mellitus; BETA-CELL; TYPE-2; COMPLICATIONS; ASSOCIATION; DYSFUNCTION; MANAGEMENT; RISK; ROSIGLITAZONE; HYPERGLYCEMIA; PREVALENCE;

D O I：

10.1136/pn-2022-003395

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Diabetes mellitus is a common condition associated with numerous complications and comorbidities. The diabetes spectrum includes type 1, type 2 and other forms of diabetes, which may be associated with medical therapies and genetic factors. Type 2 diabetes is managed with lifestyle, oral therapies, non-insulin-based injectables and subsequently insulin. Type 1 diabetes requires insulin from the time of diagnosis. In recent years, there have been considerable developments in the therapies available to treat type 2 diabetes and some of these also afford cardiorenal protection. This review summarises the nature, complications and therapeutic advances in the field of diabetes and provides a concise review for neurologists. Managing diabetes optimally prevents complications and all medical specialties need a basic understanding of the principles involved in diabetes care.

引用

页码：532 / 539

页数：9

共 50 条

[41] Online Social Capital and Health What We Know, What We Need to Know [J].

Kwon, Youngbum .

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 63 (01) :E42-E43

[42] Cross-Cultural Interaction: What We Know and What We Need to Know [J].

Adler, Nancy J. ;

Aycan, Zeynep .

ANNUAL REVIEW OF ORGANIZATIONAL PSYCHOLOGY AND ORGANIZATIONAL BEHAVIOR, VOL 5, 2018, 5 :307-333

[43] Risks and Global Supply Chains: What We Know and What We Need to Know [J].

Baldwin, Richard ;

Freeman, Rebecca .

ANNUAL REVIEW OF ECONOMICS, 2022, 14 :153-180

[44] Nonsuicidal Self-Injury: What We Know, and What We Need to Know [J].

Klonsky, E. David ;

Victor, Sarah E. ;

Saffer, Boaz Y. .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (11) :565-568

[45] Institutional Abuse of Older Adults: What We Know, What We Need to Know [J].

McDonald, Lynn ;

Beaulieu, Marie ;

Harbison, Joan ;

Hirst, Sandra ;

Lowenstein, Ariella ;

Podnieks, Elizabeth ;

Wahl, Judith .

JOURNAL OF ELDER ABUSE & NEGLECT, 2012, 24 (02) :138-160

[46] Galliformes science and species extinctions: what we know and what we need to know [J].

McGowan, P. J. K. ;

Owens, L. L. ;

Grainger, M. J. .

ANIMAL BIODIVERSITY AND CONSERVATION, 2012, 35 (02) :321-331

[47] Epigenetics in ecology and evolution: what we know and what we need to know INTRODUCTION [J].

Verhoeven, Koen J. F. ;

Vonholdt, Bridgett M. ;

Sork, Victoria L. .

MOLECULAR ECOLOGY, 2016, 25 (08) :1631-1638

[48] Prevalence of undiagnosed type 2 diabetes mellitus in Pakistan: Results of SCREEN-diabetes disease registry [J].

Mehmood, Khalid ;

Junaid, Nabeea .

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (08) :1171-1178

[49] What employees with diabetes mellitus need to cope at work: Views of employees and health professionals [J].

Detaille, Sarah I. ;

Haafkens, Joke A. ;

Hoekstra, Joost B. ;

van Dijk, Frank J. H. .

PATIENT EDUCATION AND COUNSELING, 2006, 64 (1-3) :183-190

[50] Chyluria: what does the clinician need to know? [J].

Stainer, Victoria ;

Jones, Patrick ;

Juliebo, Siri Overeng ;

Beck, Rupert ;

Hawary, Amr .

THERAPEUTIC ADVANCES IN UROLOGY, 2020, 12

← 1 2 3 4 5 →